{
    "msg": "获取章节试题成功",
    "data": {
        "test": {
            "ReturnMessage": "取数据成功",
            "APPEName": "ZY_LCZY_YTMJ",
            "GenDate": "Tue May 14 2019 23:06:44 GMT+0800 (CST)",
            "StyleItems": [
                {
                    "StyleID": 1,
                    "Style": "A1型题",
                    "Explain": "A1型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 14,
                    "TestItems": [
                        {
                            "Title": "0269126658cef8bc5f8928929a94af066dab1d2f2595f4b87ec653e7fea3cd7eec0f18b0530e92aac6e1ad9c70311cb0755f825f96ac01eed4e4c3b1e290832e",
                            "Explain": "CD4[SBjia.gif]T细胞主要识别MHC-Ⅱ类分子+APC所提呈的抗原；CD8[SBjia.gif]T细胞主要识别MHC-Ⅰ类分子+APC所提呈的抗原。急性排斥反应是同种异基因移植后最常见的排斥反应，一般在移植的数周或数月后发生。CD4[SBjia.gif]T细胞介导的针对移植物的迟发型超敏反应性炎症和CD8[SBjia.gif]T细胞介导的对移植物细胞的特异性杀伤是发生急性排斥反应的主要原因。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "NK细胞"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "B",
                                    "Content": "CD8[SBjia.gif]T细胞"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "B细胞"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "肥大细胞"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "嗜酸粒细胞"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43000371,
                            "ATestID": 43000371,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "13b39c08136616dfcd052b4263e4d843f603eab4ba266bf655bf1c66dcfab0a8603ced4bda44b944",
                            "Explain": "诱导肿瘤特异性Ag的物质是甲基胆蒽",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "B",
                            "Difficulty": "易",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "人乙肝病毒"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "甲基胆蒽"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "EB病毒"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "人乳头瘤病毒"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "单纯疱疹病毒"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002438,
                            "ATestID": 43002438,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "301d73f9fcf90f43816f6542456676e1fee89eaea221f948d5e57c03b38ef66af37f4579622fca55",
                            "Explain": "我们每个人的体内都有针对肿瘤细胞的免疫杀伤细胞,包括NK细胞、巨噬细胞和细胞毒T细胞等.NK细胞也叫自然杀伤细胞,在机体早期杀伤肿瘤细胞的免疫监视过程中具有重要作用,可以非特异性的杀伤肿瘤细胞,体内的许多细胞因子如IL2、IFNγ等都可以活化NK细胞,增强NK细胞对肿瘤细胞的杀伤功能.NK细胞主要分布在血液中和淋巴组织.巨噬细胞被IFNγ等细胞因子活化后,也具有杀伤肿瘤细胞的功能,巨噬细胞则广泛分布于全身各种组织,它可以及时发现并清除体内的肿瘤细胞,防止机体形成肿瘤.细胞毒T细胞是特异性免疫反应中的杀伤性T细胞,需要经过肿瘤抗原激活后才能发挥作用.总之体内的多种免疫杀伤细胞在抗肿瘤过程中,既可以独立作战,又可以相互配合、相互调节,最终杀伤体内的肿瘤细胞.",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "A",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "CTL"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "NK"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "Mφ"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "LAK"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "中性粒细胞"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002439,
                            "ATestID": 43002439,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "daf5df901412406b816d0e2ec4ff3889123eb8e3fcab63d96e3c59ad605b212afbc965c6381afdb2",
                            "Explain": "抗原是肿瘤免疫学的核心：1、诱导适应性免疫反应2、免疫学诊断3、肿瘤的靶向治疗",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "E",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "TAA诱导的免疫应答具有典型的特异性和记忆性"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "TSA不能成为抗体识别和清除恶变细胞的抗原成分"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "TAA被宿主识别的过程具有MHC限制性"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "TSA抗原性较弱，难以刺激机体产生抗肿瘤免疫应答"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "TSA是肿瘤免疫诊断及治疗的有效靶点"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002440,
                            "ATestID": 43002440,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "aaf81b3348f5c4a8766432f0c34c9f377390ff27e00e147d1edec400d150c60f34eb47ba94e2e176e99eed7be03362aa",
                            "Explain": "特点：特异性高而抗原性弱，表现出明显的个体特异性。同一种化学致癌剂或物理辐射诱发的肿瘤，在不同种系、同种系的不同个体、甚至是同一个体的不同部位，其免疫原性各异。由于突变的肿瘤抗原间很少有交叉成分，故应用免疫学技术诊断和治疗此类肿瘤有一定困难。",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "B",
                            "Difficulty": "易",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "特异性高，抗原性强"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "特异性高，抗原性弱"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "特异性低，抗原性强"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "特异性低，抗原性弱"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "多具有共同性表达"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002441,
                            "ATestID": 43002441,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "daf5df901412406b0e2a00b441c9ac7755784b1e27968f29b1d9f08ab0cdd05fb11f531facafa619",
                            "Explain": "血清中癌胚抗原偏高，通常是指肿瘤的复发或者肿瘤细胞活跃，但是单凭癌胚抗原的升高是不能确诊为肠癌等癌症的。",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "C",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "肿瘤抗原只存在于细胞表面"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "血清中抗甲胎蛋白抗体水平增高有助于原发性肝癌诊断"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "血清中癌胚抗原水平增高有助于结肠癌诊断"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "同种类型的肿瘤表达的肿瘤抗原相同"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "HIV与成人T淋巴细胞白血病的发病有关"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002442,
                            "ATestID": 43002442,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "b9eb8a4ba7c1f5fd1533ab916c348bd33da9cd4e105435ae3d8cd7cafdead338da8de6d1202b8653",
                            "Explain": "穿孔素储存于CTL细胞和NK细胞的胞浆颗粒中，是这些细胞杀伤靶细胞的主要效应分子。",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "C",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "特异性地识别肿瘤细胞表面的MHCI类分子"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "将肿瘤细胞内化杀伤"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "释放穿孔素"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "释放TNF-β"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "释放IFN-α"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002443,
                            "ATestID": 43002443,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8baf625e07ea32551f998b2069c3303a6d84e4666479a265a09751b92ed69dc371bcb05cd6ef11263e2fdf37e3399a9fc100c864d07540d0660371df11b45cf9",
                            "Explain": "CD8+T细胞是MHC-I类分子限制性T细胞，具有高度特异性的CTL，其杀伤机制为：a.分泌穿孔素、粒酶、淋巴毒素、TNF等杀伤肿瘤；b.通过CTL上的FasL分子与肿瘤细胞上的Fas结合启动肿瘤细胞的凋亡途径。",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "A",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "CD8[~+.gif]CTL是抗肿瘤免疫的主要效应细胞"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "CTL杀伤肿瘤细胞不受MHC限制"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "用巨噬细胞抑制剂可抑制机体内肿瘤生长"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "中性粒细胞可特异的杀伤人体内多种肿瘤"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "NK细胞通过表面的IgE Fc段受体与瘤细胞上的抗体结合发挥ADCC效应"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002444,
                            "ATestID": 43002444,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c9247763b04b5cf205273c58235476dba53aeeadb634daae0dc9f33fdcd627b19cae8a0d4b5e518504197b70532ecbbe",
                            "Explain": "肿瘤免疫逃逸（Tumorimmuneescape）是指肿瘤细胞通过多种机制逃避机体免疫系统识别和攻击，从而得以在体内生存和增殖的现象。机体免疫系统具有免疫监视功能，当体内出现恶变细胞时，免疫系统能够识别并通过免疫机制特异地清除这些“非己”细胞，抵御肿瘤的发生发展。然而，恶变细胞在某些情况下能通过多种机制逃避机体的免疫监视，在体内迅速增殖，形成肿瘤。也就是说：一方面，机体可通过天然和获得性免疫抵抗肿瘤的发生；另一方面，肿瘤细胞可通过多种机制逃避机体免疫的识别和攻击。",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "C",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "肿瘤细胞MHCⅡ类分子表达下降或缺失"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "肿瘤细胞可产生杀伤性物质"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "肿瘤细胞表面共刺激分子表达水平降低"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "肿瘤细胞在遗传上稳定，不易产生变异"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "肿瘤细胞表达大量Fas"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002445,
                            "ATestID": 43002445,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "daf5df901412406b0e2a00b441c9ac77242626b58955ef9edc2943e051b399099245f20330d7d2715e374228935de0e6",
                            "Explain": "发生了肿瘤性转化的细胞可以引起机体的免疫反应，机体的抗肿瘤免疫反应主要是细胞免疫。免疫功能低下者恶性肿瘤的发病率明显增加。说明正常机体存在免疫监视机制，可以清除发生了肿瘤性转化的细胞，起到抗肿瘤的作用。免疫监视功能的下降，可能参与了一些肿瘤的发生。肿瘤细胞也可通过减少肿瘤抗原表达等方式，逃脱免疫监视，甚至通过诱导免疫细胞的死亡，破坏机体的免疫系统。细胞免疫在抗肿瘤免疫中起主要作用。",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "B",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "Content": "体液免疫在抗肿瘤免疫中起主要作用",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "细胞免疫在抗肿瘤免疫中起主要作用",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "静止的与活化的Mφ均能杀伤肿瘤细胞",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "诊断主要依赖于肿瘤的特异性抗原的检测",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "临床使用细胞因子治疗肿瘤效果显著",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002446,
                            "ATestID": 43002446,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "87db7841eb418c789a176caa6304e1ef9c73526de937a5394c1fc1862a07877595bdc08d947d1565",
                            "Explain": "肿瘤过继免疫疗法是将自身或异体的抗肿瘤效应细胞的前体细胞，在体外采用IL-2、抗CD3单抗，特异性多肽等激活剂进行诱导、激活和扩增，然后转输给肿瘤患者，提高患者抗肿瘤免疫力，以达到治疗和预防复发的目的。常见的免疫效应细胞有：①LAK细胞：用高浓度IL-2激活病人自体或正常供者的外周血单个核细胞；②TIL细胞：从切除的瘤组织或癌性胸腹水中分离淋巴细胞，体外经IL-2诱导激活和扩增；③CD3AK细胞：用抗CD3单抗辅以小剂量IL-2激活外周血单个核细胞；④CTL细胞：用特异性多肽抗原体外诱导CTL克隆。",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "C",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "注射BCG"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "注射IL-2"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "注射TIL"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "注射病毒性肿瘤疫苗"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "E",
                                    "Content": "注射McAb[~125.gif]I"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002447,
                            "ATestID": 43002447,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "60784516521d25fd8f0edc9c9bc992b77507a1c7a6b77c10554c337e9036ea36380bd3e95a1d3c751ab580c7aa2cb4b1",
                            "Explain": "肿瘤的主动免疫治疗是指给机体输入各种具有抗原性的瘤苗（包括细胞类和蛋白类），刺激机体免疫系统产生抗肿瘤免疫应答的疗法。此种方法对于手术后清除微小的转移瘤灶和隐匿瘤、预防肿瘤转移和复发有一定的效果。",
                            "TestPoint": "肿瘤免疫及真题讲解",
                            "Answer": "B",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "BCG注射"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "抗原性疫苗的输入"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "IL-2的注射"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "抗肿瘤导向治疗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "LAK的输入"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002448,
                            "ATestID": 43002448,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "be2711c697469e3ccc80da87587141d99e07b3d199630ff5",
                            "Explain": "血浆置换法是将红斑狼疮（或其他需求清除血浆中大分子毒素的）患者的血液引入一个血浆置换装置，将分离出的血浆弃去，补充一定的新鲜血浆或者代用品，如4%人血清白蛋白，林格氏液等。来帮助清除体内可溶性免疫复合物及部分抗体，接受这一治疗的部分患者在治疗前循环免疫复合物水平很高，治疗后显著下降，常可获得较好的近期治疗效果。对肿瘤患者没有意义。",
                            "TestPoint": "移植免疫",
                            "Answer": "D",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "Content": "主动免疫治疗",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "非特异性免疫治疗",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "抗肿瘤导向治疗",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "血浆置换",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "过继免疫治疗",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002449,
                            "ATestID": 43002449,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "842525e198414eeba0eeceaff31db48a1f3a83fc39d349d382f20fc938fbd387",
                            "Explain": "肿瘤相关抗原，非肿瘤细胞特有，在正常细胞和其他组织也存在的抗原 。其含量在细胞癌变时明显增高，所以选D。",
                            "TestPoint": "肿瘤",
                            "Answer": "D",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "表达于肿瘤细胞而不表达于正常细胞"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "肿瘤细胞和正常细胞无差异性表达"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "表达于正常细胞而不表达于肿瘤细胞"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "高表达于肿瘤细胞而低表达于正常细胞"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "高表达于正常细胞而低表达于肿瘤细胞"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015075,
                            "ATestID": 43015075,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 2,
                    "Style": "A2型题",
                    "Explain": "A2型题：每一道考题是以一个小案例出现的，其下面都有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 2,
                    "TestItems": [
                        {
                            "Title": "1a5a9aa6e475b438f51775598e83176f241d425d09f7a9b755dccbe3cbc80a88d51bada7850ff40740be20761541d1a90a8828c255fde9643f1639a70176e87f7facd90863ca51f800362dba7471d676a593db75bc4bff04f5f506c4284ab73bdff5173c3c873cfa65bd6857153f02ab860354d8c6a33e850787ccc48d7c2d24ac55a27caa44112d843fd365a5af4ee2",
                            "Explain": "LAK细胞并非是一个独立的淋巴群或亚群，而是NK细胞或T细胞体外培养时，在高剂量IL-2等细胞因子诱导下成为能够杀伤NK不敏感肿瘤细胞的杀伤细胞，称为淋巴因子激活的杀伤细胞（lymphokineactivatedkillercells，LAK）。目前应用LAK细胞过继免疫疗法（adoptiveimmunotherapy）与直接注射IL-2等细胞因子联合治疗某些肿瘤，已获得一定的疗效。LAK细胞1.LAK的发现1982年Grimm等首先报道外周血单个核细胞（PBMC）中加入IL-2体外培养4-6天，能诱导出一种非特异笥的杀伤细胞，这类细胞可以杀伤多种对CTL、NK不敏感的肿瘤细胞。目前尚未发现LAK细胞特有的表面标志，许多实验表明，LAK细胞的前体细胞是NK细胞和T细胞。2.LAK的临床应用1984年11月Rosenberg研究组经美国食品和药品检验局（UsFoodandDrugAdministration，FDA）批准下，首次应用IL-2与LAK协同治疗25例肾细胞癌、黑素瘤、肺癌、结肠癌等肿瘤患者。治疗用LAK细胞数量在0.6-18.4*1010，IL-2用量2.8*105-3.32*106U/kg.其中11例肿瘤缩小超过50%，1例黑素瘤完全消退。1988年该研究组总结了IL-2与LAK细胞协同治疗222例肿瘤患者，其中16便患者肿瘤转移灶完全消退，26例患者肿瘤消退50%以上，该疗法对转移性肾细胞癌、黑素瘤、结肠癌和非何杰金氏淋巴瘤患者的疗效较显著。有报道乳腺癌、膀胱癌局部应用IL-2进行治疗也获得明显疗效。由于IL-2用量大，在治疗过程中可出现毒副反应，最常见和最严重的毒副作用是出现毛细血管渗漏综合征（capillaryleaksyndrome，CLS），主要表现为全身性水肿和多器官功能失调，可引起胸腹腔积液、肺间质水肿和充血性心力衰竭。引地卢CLS的机理可能与内皮细胞损伤和产生血管活性物质有关。",
                            "TestPoint": "HLA在医学上的意义",
                            "Answer": "A",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "Mφ"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "NK"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "Tc"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "LAK"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "TIL"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002450,
                            "ATestID": 43002450,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "137e84b0a4e115350f9c64ab07a3f9147d64277d590de09373e2f573b9d63e7ce815300bc17a4e56d1e806754f3d2ecc1ba6830d8c4def4e4fb2d1ac92c31c0f53c658c5f626b2b525cbb6f4915c94920f79acc2f032f4e6fc2bba92b030f5a400f6ba6bbc8d6aba5ec2f42f1574ccbf874cffd0a1cd47cafbc10a8949e327c6a193c17130916c4aa7d8945a3be080bcb5ce6640a17481e7dfe0303bcb03f1acf0c98881d0e3bd819dd467c832e579e82e82864462718faeac5669f9f66c44b7",
                            "Explain": "基因治疗（genetherapy）是指将外源正常基因导入靶细胞，以纠正或补偿因基因缺陷和异常引起的疾病，以达到治疗目的。也包括转基因等方面的技术应用。也就是将外源基因通过基因转移技术将其插入病人的适当的受体细胞中，使外源基因制造的产物能治疗某种疾病。",
                            "TestPoint": "移植免疫",
                            "Answer": "A",
                            "Difficulty": "易",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "基因治疗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "过继免疫治疗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "主动特异性免疫治疗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "免疫导向治疗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "以上都不是"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002451,
                            "ATestID": 43002451,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 3,
                    "Style": "B1型题",
                    "Explain": "B1型题：以下提供若干组考题，每组考题共用在考题前列出的A、B、C、D、E五个备选答案。请从中选择一个与问题关系最密切的答案。某个备选答案可能被选择一次、多次或不被选择。",
                    "Score": 1,
                    "Type": "BTEST",
                    "SubType": "单项",
                    "TestCount": 8,
                    "TestItems": [
                        {
                            "Title": "8057599c1f12e090ec9e0aa3f9b6be7cb6311c163cce17a4",
                            "Explain": "结肠直肠癌病人血CEA升高，CEA指的癌胚抗原,这是一种肿瘤标志物检查。",
                            "TestPoint": "结肠癌的临床表现及治疗",
                            "Answer": "C",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "血CA199升高"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "血PSA升高"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "血CEA升高"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "血AFP升高"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "血酸性磷酸酶升高"
                                }
                            ],
                            "AllTestID": 43002452,
                            "BTestID": 43000604,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43000604,
                                    "Title": "8057599c1f12e090ec9e0aa3f9b6be7cb6311c163cce17a4",
                                    "Explain": "结肠直肠癌病人血CEA升高，CEA指的癌胚抗原,这是一种肿瘤标志物检查。",
                                    "TestPoint": "结肠癌的临床表现及治疗",
                                    "Answer": "C",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000605,
                                    "Title": "625ffe858d21a98253dfe2d5eb9b706d",
                                    "Explain": "胰腺癌病人血CA199升高，血清CA199是一种肿瘤标志物,升高多见于胰腺癌,也可见于结肠癌、肝癌、胆囊癌,最近发现在肺癌、卵巢癌中的阳性率也很高。",
                                    "TestPoint": "慢性胰腺炎",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000606,
                                    "Title": "09a710914cd50adde985eddc4cb99b486556d9940764836c",
                                    "Explain": "原发性肝癌病人血AFP升高。",
                                    "TestPoint": "肝癌的临床表现及治疗",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000607,
                                    "Title": "2456a72203b55ef97d7b929305a0614b6fac32133a0f8add",
                                    "Explain": "前列腺癌病人血PSA升高，血清PSA是前腺癌的特异性标志物。",
                                    "TestPoint": "前列腺癌和睾丸肿瘤",
                                    "Answer": "B",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "9664b18f90e4e81d50e58f88ccb0b0b6984db364aea2133caecd2795e2eaf32d",
                            "Explain": "与原发性肝癌有关乙型肝炎病毒。",
                            "TestPoint": "原发性肝癌",
                            "Answer": "C",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "EBV"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "人乳头瘤病毒"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "乙型肝炎病毒"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "HIV"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "人嗜T淋巴细胞病毒-1"
                                }
                            ],
                            "AllTestID": 43002453,
                            "BTestID": 43000608,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 456,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43000608,
                                    "Title": "9664b18f90e4e81d50e58f88ccb0b0b6984db364aea2133caecd2795e2eaf32d",
                                    "Explain": "与原发性肝癌有关乙型肝炎病毒。",
                                    "TestPoint": "原发性肝癌",
                                    "Answer": "C",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000609,
                                    "Title": "4ba9e9e8cba62f85ecff3ae1bbcbd1395dfdee1de1c9b7ad9ecf109c1133e823",
                                    "Explain": "与B淋巴细胞瘤发生有关的死EBV。",
                                    "TestPoint": "淋巴瘤",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000610,
                                    "Title": "78b4a4f4268e1674e8000e88d05e1764bce7bc68bfc57d48267678230a0232beec7358109e624297f0443889ccb01303",
                                    "Explain": "与成人T淋巴细胞白血病发生有关的是人嗜T淋巴细胞病毒-1。",
                                    "TestPoint": "白血病",
                                    "Answer": "E",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000611,
                                    "Title": "9aad5845f80a0f2b78c030298e7f74a1c3e7d93c482c523a1bea8b871e2ac683",
                                    "Explain": "与人宫颈癌发生有关的是人乳头瘤病毒。",
                                    "TestPoint": "宫颈癌",
                                    "Answer": "B",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        }
                    ]
                }
            ]
        },
        "isVip": 0,
        "testInfo": [
            {
                "AllTestID": 43000371,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43000371,
                        "ChildTableID": -1,
                        "UserCount": 734,
                        "RightCount": 487,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 10
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43000371,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 10
            },
            {
                "AllTestID": 43002438,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002438,
                        "ChildTableID": -1,
                        "UserCount": 782,
                        "RightCount": 381,
                        "FavCount": 26,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 10
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002438,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 10
            },
            {
                "AllTestID": 43002439,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002439,
                        "ChildTableID": -1,
                        "UserCount": 767,
                        "RightCount": 444,
                        "FavCount": 22,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002439,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43002440,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002440,
                        "ChildTableID": -1,
                        "UserCount": 741,
                        "RightCount": 373,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 14
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002440,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 14
            },
            {
                "AllTestID": 43002441,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002441,
                        "ChildTableID": -1,
                        "UserCount": 732,
                        "RightCount": 362,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002441,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43002442,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002442,
                        "ChildTableID": -1,
                        "UserCount": 701,
                        "RightCount": 329,
                        "FavCount": 11,
                        "DiscussionCount": 2,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002442,
                    "ChildTableID": -1
                },
                "DiscussionCount": 2,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43002443,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002443,
                        "ChildTableID": -1,
                        "UserCount": 702,
                        "RightCount": 347,
                        "FavCount": 12,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002443,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43002444,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002444,
                        "ChildTableID": -1,
                        "UserCount": 650,
                        "RightCount": 390,
                        "FavCount": 10,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002444,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002445,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002445,
                        "ChildTableID": -1,
                        "UserCount": 660,
                        "RightCount": 334,
                        "FavCount": 13,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002445,
                    "ChildTableID": -1
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43002446,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002446,
                        "ChildTableID": -1,
                        "UserCount": 630,
                        "RightCount": 388,
                        "FavCount": 6,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002446,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43002447,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002447,
                        "ChildTableID": -1,
                        "UserCount": 663,
                        "RightCount": 261,
                        "FavCount": 18,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002447,
                    "ChildTableID": -1
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43002448,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002448,
                        "ChildTableID": -1,
                        "UserCount": 627,
                        "RightCount": 376,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002448,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43002449,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002449,
                        "ChildTableID": -1,
                        "UserCount": 576,
                        "RightCount": 489,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002449,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43015075,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015075,
                        "ChildTableID": -1,
                        "UserCount": 569,
                        "RightCount": 410,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015075,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43002450,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002450,
                        "ChildTableID": -1,
                        "UserCount": 736,
                        "RightCount": 329,
                        "FavCount": 24,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002450,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43002451,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002451,
                        "ChildTableID": -1,
                        "UserCount": 662,
                        "RightCount": 350,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 1
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002451,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 1
            },
            {
                "AllTestID": 43002452,
                "ChildTableID": 43000604,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002452,
                        "ChildTableID": 43000604,
                        "UserCount": 838,
                        "RightCount": 622,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002452,
                    "ChildTableID": 43000604
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43002452,
                "ChildTableID": 43000605,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002452,
                        "ChildTableID": 43000605,
                        "UserCount": 846,
                        "RightCount": 547,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002452,
                    "ChildTableID": 43000605
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43002452,
                "ChildTableID": 43000606,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002452,
                        "ChildTableID": 43000606,
                        "UserCount": 747,
                        "RightCount": 674,
                        "FavCount": 5,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002452,
                    "ChildTableID": 43000606
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43002452,
                "ChildTableID": 43000607,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002452,
                        "ChildTableID": 43000607,
                        "UserCount": 828,
                        "RightCount": 633,
                        "FavCount": 15,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002452,
                    "ChildTableID": 43000607
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43002453,
                "ChildTableID": 43000608,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002453,
                        "ChildTableID": 43000608,
                        "UserCount": 629,
                        "RightCount": 539,
                        "FavCount": 2,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002453,
                    "ChildTableID": 43000608
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43002453,
                "ChildTableID": 43000609,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002453,
                        "ChildTableID": 43000609,
                        "UserCount": 696,
                        "RightCount": 414,
                        "FavCount": 12,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002453,
                    "ChildTableID": 43000609
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002453,
                "ChildTableID": 43000610,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002453,
                        "ChildTableID": 43000610,
                        "UserCount": 634,
                        "RightCount": 532,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002453,
                    "ChildTableID": 43000610
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002453,
                "ChildTableID": 43000611,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002453,
                        "ChildTableID": 43000611,
                        "UserCount": 618,
                        "RightCount": 557,
                        "FavCount": 1,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 1
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002453,
                    "ChildTableID": 43000611
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 1
            }
        ],
        "info": [],
        "encoded": 1,
        "examHistoryID": 0,
        "yimoinfo": [],
        "UserTime": 0
    },
    "status": 200
}